|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent BBIO insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why BBIO insider buys are important for investors to follow.
Date | Insider | Price | Amount |
12-28-2021 Insider Buy |
Hannah Valantine
|
$12.96
CAGR »
|
$44,475.94 3,433 shares |
3-15-2022 Insider Buy |
Andrea Ellis Director |
$8.39
CAGR »
|
$100,680.00 12,000 shares |
3-14-2022 Insider Buy |
Douglas A. Dachille Director |
$8.19
CAGR »
|
$81,934.00 10,000 shares |
1-5-2022 Insider Buy |
Douglas A. Dachille Director |
$16.36
CAGR »
|
$163,650.00 10,000 shares |
12-29-2021 Insider Buy |
Brent L. Saunders Director |
$14.48
CAGR »
|
$254,879.68 17,600 shares |
12-30-2021 Insider Buy |
Andrew Lo Director |
$13.18
CAGR »
|
$98,850.00 7,500 shares |
12-29-2021 Insider Buy |
Hannah Valantine Director |
$14.23
CAGR »
|
$25,101.72 1,764 shares |
12-29-2021 Insider Buy |
Fred Hassan Director |
$14.17
CAGR »
|
$273,390.29 19,300 shares |
12-29-2021 Insider Buy |
James C. Momtazee Director |
$14.50
CAGR »
|
$1,160,000.00 80,000 shares |
12-30-2021 Insider Buy |
Ronald J. Daniels Director |
$13.49
CAGR »
|
$298,678.53 22,147 shares |
2-17-2021 Insider Buy |
Randal W. Scott Director |
$62.50
CAGR »
|
$1,000,000.00 16,000 shares |
2-17-2021 Insider Buy |
Brian C. Stephenson See Remarks |
$62.50
CAGR »
|
$500,000.00 8,000 shares |
7-1-2019 Insider Buy |
Uma Sinha Chief Scientific Officer |
$17.00
CAGR »
|
$238,000.00 14,000 shares |
7-1-2019 Insider Buy |
Genetic Disorder L.P. KKR >10% Owner |
$17.00
CAGR »
|
$45,000,700.00 2,647,100 shares |
7-1-2019 Insider Buy |
Brian C. Stephenson See Remark |
$17.00
CAGR »
|
$943,500.00 55,500 shares |
7-1-2019 Insider Buy |
Michael Thomas Henderson See Remarks |
$17.00
CAGR »
|
$119,000.00 7,000 shares |
6-27-2019 Insider Buy |
Global Investors LP Viking >10% Owner |
$17.00
CAGR »
|
$80,000,300.00 4,705,900 shares |
6-27-2019 Insider Buy |
VIKING GLOBAL PERFORMANCE LLC >10% Owner |
$17.00
CAGR »
|
$80,000,300.00 4,705,900 shares |
Also See: Institutional Holders of BBIO
Also See: SEC filings
Below we present the annualized performance delivered by BBIO stock since 12-28-2021 (the date of the most recent
insider purchase). The performance of the investment from the time BBIO insider buying occurred is the ultimate
test of whether insiders were right about BBIO being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/29/2021 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$14.19 |
|
End price/share: |
$24.88 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
75.33% |
|
Average Annual Total Return: |
27.34% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$17,533.29 |
|
Years: |
2.32 |
|
BBIO Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent BBIO insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding BBIO
|
|